FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
Reminder - Dr. Buff Mair is the new CTS Medical Director. Several of the CTS client forms specify li...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...